Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
9,273,979
-
Shares change
-
+393,018
-
Total reported value, excl. options
-
$44,122,000
-
Value change
-
+$4,508,577
-
Put/Call ratio
-
11.4%
-
Number of buys
-
14
-
Number of sells
-
-17
-
Price
-
$4.76
Significant Holders of InflaRx N.V. - COM (IFRX) as of Q4 2021
49 filings reported holding IFRX - InflaRx N.V. - COM as of Q4 2021.
InflaRx N.V. - COM (IFRX) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,273,979 shares
.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (3,285,000 shares), Sofinnova Investments, Inc. (1,161,736 shares), ORBIMED ADVISORS LLC (875,297 shares), MORGAN STANLEY (873,661 shares), Walleye Capital LLC (530,432 shares), Laurion Capital Management LP (500,000 shares), Ikarian Capital, LLC (331,048 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (325,000 shares), Bank Julius Baer & Co. Ltd, Zurich (197,607 shares), and Invesco Ltd. (159,396 shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.